Johns Hopkins Sibley Memorial Hospital

Washington D.C., District of Columbia 21287

2 studies enrolling now · 9 studies all time

What they study most

Adenocarcinoma of Esophagus, Advanced Solid Tumor, BRAF Gene Alteration, BRAF Gene Mutation, Biliary Tract Carcinoma, Bladder Cancer, Brain Cancer, Central Nervous System Diseases, GBM, Gastric Adenocarcinoma, Gastroesophageal Cancer (GC), Glioblastoma (GBM)

Studies at this site

• Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII — Recruiting now
• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors — Recruiting now
• First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01) — Running, not enrolling
• Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations — Stopped early
• A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy — Completed
• KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC — Stopped early
• Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100) — Stopped early
• A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV — Completed
• A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension — Completed